Company Filing History:
1 out of 1,124 
1 out of 1 
1 out of 832,966 Years Active: 2006-2025
Title: Yoon Ho Chung: Innovator in Benign Prostatic Hyperplasia Treatment
Introduction
Yoon Ho Chung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical devices, particularly in the treatment of benign prostatic hyperplasia (BPH). With a total of 3 patents to his name, Chung's work is paving the way for innovative solutions in urology.
Latest Patents
Chung's latest patents focus on advanced treatment devices for benign prostatic hyperplasia. One of his inventions includes a benign prostatic hyperplasia treatment device that features anchor assemblies. This device consists of a first anchor positioned at the outer surface of the prostate gland, obstructing the prostatic urethra, and a second anchor located inside the prostate gland. These anchors are connected by a ligature, which compresses the prostate tissue to secure the opening of the prostatic urethra. Additionally, a sheath is inserted into the urethra, equipped with a needle that guides the anchor assembly for deployment at the prostate gland. Another patent describes a similar device, where a pair of anchors compresses the prostatic tissues continuously to maintain the opening of the prostatic urethra.
Career Highlights
Throughout his career, Yoon Ho Chung has worked with various institutions, including the Industry-University Cooperation Foundation at Hanyang University and Cedars Health Inc. His experience in these organizations has allowed him to develop and refine his innovative medical devices.
Collaborations
Chung has collaborated with notable colleagues such as Geon Sun Park and Young-Ho Kim. Their combined expertise has contributed to the advancement of medical technologies in the field of urology.
Conclusion
Yoon Ho Chung's contributions to the treatment of benign prostatic hyperplasia through his innovative devices highlight his role as a leading inventor in the medical field. His patents reflect a commitment to improving patient care and advancing medical technology.